{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:51:24Z","timestamp":1789102284639,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10930012310012"],"award-info":[{"award-number":["10930012310012"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10930012310012"],"award-info":[{"award-number":["10930012310012"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10930012310012"],"award-info":[{"award-number":["10930012310012"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10930012310012"],"award-info":[{"award-number":["10930012310012"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10930012310012"],"award-info":[{"award-number":["10930012310012"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Dementia risk reduction through lifestyle modification has much potential but is not yet implemented in routine clinical care. Currently, there are no preventive interventions available for memory clinic patients. Therefore, the aim of The Lifestyle Intervention in the memory clinics of General and academic Hospitals Trial (LIGHT) is to examine the (cost)effectiveness of a multidomain intervention combining lifestyle coaching with risk self-management for patients with subjective cognitive decline (SCD) and mild cognitive impairment (MCI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      LIGHT is a 1-year multi-center randomized controlled trial for dementia risk reduction by improving brain health through lifestyle modifications in memory clinic patients without dementia. Starting early 2025, the trial aims to include 300 older adults (\u2265\u200950 years) with SCD or MCI, with presence of \u2265\u20092 modifiable dementia risk factors, recruited via the memory clinics of Dutch hospitals. Participants are randomized 1:1 to either the intervention group or control group. The intervention consists of three components: (1) three individual sessions with a certified lifestyle coach to set and work on personal goals, (2) vouchers for access to brain-healthy services from local providers, and (3) access to an online self-management platform (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.breinzorg.nl\" ext-link-type=\"uri\">www.breinzorg.nl<\/jats:ext-link>\n                      ) providing psychoeducation on dementia risk reduction through lifestyle. The control group receives general health advice. The primary outcome is 1-year change in modifiable dementia risk captured by the LIfestyle for BRAin Health 2 (LIBRA2) index consisting of coronary heart disease, diabetes, hypercholesterolemia, hypertension, depression, obesity, smoking, high physical activity, and chronic kidney disease, high alcohol intake, high cognitive activity, healthy diet, hearing impairment, sleep disturbances, and social participation. Secondary outcomes include cognitive functioning, health-related quality of life, activities of daily living, self-efficacy, care use, as well as change in individual risk factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LIGHT will provide insight into the implementation and (cost-)effectiveness of a lifestyle intervention for indicated prevention in a memory clinic setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Clinicaltrials.gov: NCT06832761 (date 2025-02-18), OMON: 57,198.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-025-01947-9","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:14:07Z","timestamp":1767867247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Lifestyle Intervention in memory clinics of General and academic Hospitals Trial (LIGHT): Rationale and study design of a randomized controlled trial to reduce modifiable dementia risk"],"prefix":"10.1186","volume":"18","author":[{"given":"V.","family":"van Gils","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Waterink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C. P. M.","family":"Wimmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G. M.","family":"Jelsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"de Vugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Handels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A. M.","family":"Sikkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. M.","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Deckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Zwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"1947_CR1","doi-asserted-by":"publisher","first-page":"765584","DOI":"10.3389\/fneur.2021.765584","volume":"12","author":"N Chowdhary","year":"2022","unstructured":"Chowdhary N, Barbui C, Anstey KJ, Kivipelto M, Barbera M, Peters R, et al. Reducing the risk of cognitive decline and dementia: WHO recommendations. Front Neurol. 2022;12:765584.","journal-title":"Front Neurol"},{"issue":"2","key":"1947_CR2","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"issue":"10452","key":"1947_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572\u2013628.","journal-title":"Lancet"},{"issue":"3","key":"1947_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/gps.4245","volume":"30","author":"K Deckers","year":"2015","unstructured":"Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Mu\u00f1oz S\u00e1nchez JL, Anstey KJ, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry. 2015;30(3):234\u201346.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"1947_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1474-4422(17)30431-3","volume":"17","author":"M Kivipelto","year":"2018","unstructured":"Kivipelto M, Mangialasche F, Ngandu T, Eg JJE, Mart\u00edn N, Soininen H, et al. World wide fingers will advance dementia prevention. Lancet Neurol. 2018;17(1):27.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1947_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/alz.13486","volume":"20","author":"AE Z\u00fclke","year":"2024","unstructured":"Z\u00fclke AE, Pabst A, Luppa M, Roehr S, Seidling H, Oey A, et al. A multidomain intervention against cognitive decline in an at-risk\u2010population in Germany: results from the cluster\u2010randomized AgeWell. de trial. Alzheimers Dement. 2024;20(1):615\u201328.","journal-title":"Alzheimers Dement"},{"key":"1947_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2024.104701","volume":"152","author":"X Meng","year":"2024","unstructured":"Meng X, Su J, Gao T, Ma D, Zhao Y, Fang S, et al. Multidomain interventions based on a life-course model to prevent dementia in at-risk Chinese older adults: a randomized controlled trial. Int J Nurs Stud. 2024;152:104701.","journal-title":"Int J Nurs Stud"},{"issue":"9984","key":"1947_CR8","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255\u201363.","journal-title":"Lancet"},{"issue":"8","key":"1947_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jama.2025.12923","volume":"334","author":"LD Baker","year":"2025","unstructured":"Baker LD, Espeland MA, Whitmer RA, Snyder HM, Leng X, Lovato L, et al. Structured vs self-guided multidomain lifestyle interventions for global cognitive function: the US POINTER randomized clinical trial. JAMA. 2025;334(8):681\u201391.","journal-title":"JAMA"},{"issue":"5","key":"1947_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","volume":"16","author":"S Andrieu","year":"2017","unstructured":"Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, et al. Effect of long-term Omega 3 polyunsaturated fatty acid supplement ation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017;16(5):377\u201389.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1947_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/JAD-190016","volume":"70","author":"JE Park","year":"2019","unstructured":"Park JE, Jeon SY, Kim SA, Kim JH, Kim SH, Lee KW, et al. A multidomain intervention for modifying lifestyle habits reduces the dementia risk in community-dwelling older adults: a single-blinded randomized controlled pilot study. J Alzheimers Dis. 2019;70(1):51\u201360.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1947_CR12","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/alz.13838","volume":"20","author":"T Sakurai","year":"2024","unstructured":"Sakurai T, Sugimoto T, Akatsu H, Doi T, Fujiwara Y, Hirakawa A, et al. Japan-multimodal intervention trial for the prevention of dementia: a randomized controlled trial. Alzheimers Dement. 2024;20(6):3918\u201330.","journal-title":"Alzheimers Dement"},{"key":"1947_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/13872877251314892","author":"FG Wittmann","year":"2025","unstructured":"Wittmann FG, Pabst A, Z\u00fclke A, Luppa M, Cardona MI, Boekholt M, et al. Adherence to intervention components: the key to success? Analysis on health-related outcomes of the AgeWell. de intervention to preserve cognition. J Alzheimers Dis. 2025. https:\/\/doi.org\/10.1177\/13872877251314892.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"1947_CR14","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/alz.12281","volume":"17","author":"K Deckers","year":"2021","unstructured":"Deckers K, K\u00f6hler S, Ngandu T, Antikainen R, Laatikainen T, Soininen H, et al. Quantifying dementia prevention potential in the FINGER randomized controlled trial using the LIBRA prevention index. Alzheimers Dement. 2021;17(7):1205\u201312.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1947_CR15","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/S2666-7568(24)00068-0","volume":"5","author":"EPM van Charante","year":"2024","unstructured":"van Charante EPM, Hoevenaar-Blom MP, Song M, Andrieu S, Barnes L, Birck C, et al. Prevention of dementia using mobile phone applications (PRODEMOS): a multinational, randomised, controlled effectiveness\u2013implementation trial. Lancet Healthy Longev. 2024;5(6):e431\u201342.","journal-title":"Lancet Healthy Longev"},{"issue":"8","key":"1947_CR16","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1002\/alz.14097","volume":"20","author":"AE Z\u00fclke","year":"2024","unstructured":"Z\u00fclke AE, Pabst A, Luppa M, Oey A, Weise S, Fankh\u00e4nel T, et al. <article-title update=\"added\">Effects of a multidomain intervention against cognitive decline on dementia risk profiles \u2014 results from the AgeWell.de trial. Alzheimers Dement. 2024;20(8):5684\u201394.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1947_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","volume":"67","author":"F Jessen","year":"2010","unstructured":"Jessen F, Wiese B, Bachmann C, Eifflaender-Gorfer S, Haller F, K\u00f6lsch H, et al. Prediction of dementia by subjective memory impairment: effects of severity and Temporal association with cognitive impairment. Arch Gen Psychiatry. 2010;67(4):414\u201322.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"1947_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jalz.2018.10.003","volume":"15","author":"RE Slot","year":"2019","unstructured":"Slot RE, Sikkes SA, Berkhof J, Brodaty H, Buckley R, Cavedo E, et al. Subjective cognitive decline and rates of incident Alzheimer\u2019s disease and non\u2013Alzheimer\u2019s disease dementia. Alzheimers Dement. 2019;15(3):465\u201376.","journal-title":"Alzheimers Dement"},{"key":"1947_CR19","unstructured":"World Health Organization. Global status report on the public health response to dementia. 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240033245."},{"issue":"1","key":"1947_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01691-0","volume":"17","author":"N Soldevila-Domenech","year":"2025","unstructured":"Soldevila-Domenech N, Ayala-Garcia A, Barbera M, Lehtisalo J, Forcano L, Diaz-Ponce A, et al. Adherence and intensity in multimodal lifestyle-based interventions for cognitive decline prevention: state-of-the-art and future directions. Alzheimers Res Ther. 2025;17(1):61.","journal-title":"Alzheimers Res Ther"},{"key":"1947_CR21","doi-asserted-by":"crossref","unstructured":"Hopewell S, Chan AW, Collins GS, Hr\u00f3bjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. Lancet. 2025;405(10489):1633\u201340.","DOI":"10.1016\/S0140-6736(25)00672-5"},{"issue":"3","key":"1947_CR22","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/alz.13577","volume":"20","author":"C Rosenau","year":"2024","unstructured":"Rosenau C, K\u00f6hler S, Soons LM, Anstey KJ, Brayne C, Brodaty H, et al. Umbrella review and Delphi study on modifiable factors for dementia risk reduction. Alzheimers Dement. 2024;20(3):2223\u201339.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1947_CR23","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3233\/JAD-240666","volume":"101","author":"C Rosenau","year":"2024","unstructured":"Rosenau C, K\u00f6hler S, van Boxtel M, Tange H, Deckers K. Validation of the updated \u201cLIfestyle for BRAin health\u201d(LIBRA) index in the English Longitudinal Study of Ageing and Maastricht Aging Study. J Alzheimers Dis. 2024;101(4):1237\u201348.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1947_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1474-4422(19)30368-0","volume":"19","author":"F Jessen","year":"2020","unstructured":"Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19(3):271\u20138.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1947_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183\u201394.","journal-title":"J Intern Med"},{"key":"1947_CR26","volume-title":"Motivational interviewing: Helping people change","author":"WR Miller","year":"2012","unstructured":"Miller WR, Rollnick S. Motivational interviewing: Helping people change. Guilford press; 2012."},{"issue":"2","key":"1947_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3233\/JAD-230794","volume":"97","author":"VE Schr\u00f6der","year":"2024","unstructured":"Schr\u00f6der VE, Skrozic A, Erz D, Kaysen A, Fritz JV, Loureiro JM, et al. Programme dementia prevention (PDP): a nationwide program for personalized prevention in Luxembourg. J Alzheimers Dis. 2024;97(2):791\u2013804.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1947_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/JAD-161208","volume":"58","author":"SJ Vos","year":"2017","unstructured":"Vos SJ, Van Boxtel MP, Schiepers OJ, Deckers K, De Vugt M, Carri\u00e8re I, et al. Modifiable risk factors for prevention of dementia in midlife, late life and the oldest-old: validation of the LIBRA index. J Alzheimers Dis. 2017;58(2):537\u201347.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1947_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/gps.5235","volume":"35","author":"K Deckers","year":"2020","unstructured":"Deckers K, Barbera M, K\u00f6hler S, Ngandu T, van Boxtel M, Rusanen M, et al. Long-term dementia risk prediction by the LIBRA score: a 30\u2010year follow\u2010up of the CAIDE study. Int J Geriatr Psychiatry. 2020;35(2):195\u2013203.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"13","key":"1947_CR30","doi-asserted-by":"publisher","first-page":"e1300","DOI":"10.1212\/WNL.0000000000012572","volume":"97","author":"IS Heger","year":"2021","unstructured":"Heger IS, Deckers K, Schram MT, Stehouwer CD, Dagnelie PC, van der Kallen CJ, et al. Associations of the lifestyle for brain health index with structural brain changes and cognition: results from the Maastricht study. Neurology. 2021;97(13):e1300\u201312.","journal-title":"Neurology"},{"issue":"1","key":"1947_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3233\/JAD-170731","volume":"62","author":"A Pons","year":"2018","unstructured":"Pons A, LaMonica HM, Mowszowski L, K\u00f6hler S, Deckers K, Naismith SL. Utility of the LIBRA index in relation to cognitive functioning in a clinical health seeking sample. J Alzheimers Dis. 2018;62(1):373\u201384.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1947_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3233\/JAD-190495","volume":"72","author":"F Franchini","year":"2019","unstructured":"Franchini F, Musicco M, Ratto F, Storti G, Shofany J, Caltagirone C, et al. The LIBRA index in relation to cognitive function, functional independence, and psycho-behavioral symptoms in a sample of non-institutionalized seniors at risk of dementia. J Alzheimers Dis. 2019;72(3):717\u201331.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"1947_CR33","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/alz.12169","volume":"16","author":"N Coley","year":"2020","unstructured":"Coley N, Hoevenaar-Blom MP, van Dalen JW, van Moll EP, Kivipelto M, Soininen H, et al. Dementia risk scores as surrogate outcomes for lifestyle\u2010based multidomain prevention trials\u2014rationale, preliminary evidence and challenges. Alzheimer\u2019s Dement. 2020;16(12):1674\u201385.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1947_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0389-4","volume":"10","author":"T van Middelaar","year":"2018","unstructured":"van Middelaar T, Hoevenaar-Blom MP, van Gool WA, van Moll EP, van Dalen J-W, Deckers K, et al. Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the prediva trial using the LIBRA index. Alzheimers Res Ther. 2018;10:1\u201310.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1947_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01495-8","volume":"16","author":"K Deckers","year":"2024","unstructured":"Deckers K, Zwan MD, Soons LM, Waterink L, Beers S, van Houdt S, et al. A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults\u2014study design and baseline characteristics of the FINGER-NL randomized controlled trial. Alzheimers Res Ther. 2024;16(1):126.","journal-title":"Alzheimers Res Ther"},{"key":"1947_CR36","doi-asserted-by":"publisher","first-page":"765454","DOI":"10.3389\/fneur.2021.765454","volume":"12","author":"KJ Anstey","year":"2022","unstructured":"Anstey KJ, Zheng L, Peters R, Kootar S, Barbera M, Stephen R, et al. Dementia risk scores and their role in the implementation of risk reduction guidelines. Front Neurol. 2022;12:765454.","journal-title":"Front Neurol"},{"issue":"6","key":"1947_CR37","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3945\/jn.110.135566","volume":"141","author":"H Schr\u00f6der","year":"2011","unstructured":"Schr\u00f6der H, Fit\u00f3 M, Estruch R, Mart\u00ednez-Gonz\u00e1lez MA, Corella D, Salas-Salvad\u00f3 J, et al. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr. 2011;141(6):1140\u20135.","journal-title":"J Nutr"},{"issue":"10","key":"1947_CR38","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/oxfordjournals.annonc.a058097","volume":"3","author":"E Riboli","year":"1992","unstructured":"Riboli E. Nutrition and cancer: background and rationale of the European prospective investigation into cancer and nutrition (EPIC). Ann Oncol. 1992;3(10):783\u201391.","journal-title":"Ann Oncol"},{"issue":"1","key":"1947_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12134","volume":"7","author":"JE Galvin","year":"2021","unstructured":"Galvin JE, Tolea MI, Chrisphonte S. The cognitive & leisure activity scale (CLAS): a new measure to quantify cognitive activities in older adults with and without cognitive impairment. Alzheimers Dement Transl Res Clin Interv. 2021;7(1):e12134.","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"issue":"9","key":"1947_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"1947_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.anr.2012.08.004","volume":"6","author":"E-H Lee","year":"2012","unstructured":"Lee E-H. Review of the psychometric evidence of the perceived stress scale. Asian Nurs Res. 2012;6(4):121\u20137.","journal-title":"Asian Nurs Res"},{"key":"1947_CR42","unstructured":"Meijman T, de Vries-Griever A, De Vries G, Kampman R. The evaluation of the Groningen sleep quality scale. Groningen: Heymans Bulletin (HB 88-13-EX). 1988;2006."},{"issue":"4","key":"1947_CR43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/geront\/46.4.503","volume":"46","author":"J Lubben","year":"2006","unstructured":"Lubben J, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, Beck JC, et al. Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist. 2006;46(4):503\u201313.","journal-title":"Gerontologist"},{"issue":"2","key":"1947_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10433-010-0144-6","volume":"7","author":"J De Jong Gierveld","year":"2010","unstructured":"De Jong Gierveld J, Van Tilburg T. The de jong gierveld short scales for emotional and social loneliness: tested on data from 7 countries in the UN generations and gender surveys. Eur J Ageing. 2010;7(2):121\u201330.","journal-title":"Eur J Ageing"},{"issue":"4","key":"1947_CR45","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3233\/JAD-240229","volume":"99","author":"S Van Asbroeck","year":"2024","unstructured":"Van Asbroeck S, K\u00f6hler S, Wimmers SCPM, Muris JWM, van Boxtel MPJ, Deckers K. Multidomain dementia risk reduction in primary care is feasible: a proof-of-concept study. J Alzheimers Dis. 2024;99(4):1455\u201371. https:\/\/doi.org\/10.3233\/JAD-240229.","journal-title":"J Alzheimers Dis"},{"key":"1947_CR46","unstructured":"Bouma JM, Mulder JL, Lindeboom J. Neuropsychologische diagnostiek: handboek. Amsterdam: Swets & Zeitlinger; 1996."},{"issue":"3","key":"1947_CR47","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1017\/S1355617705050344","volume":"11","author":"W Van Der Elst","year":"2005","unstructured":"Van Der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. Rey\u2019s verbal learning test: normative data for 1855 healthy participants aged 24\u201381 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc. 2005;11(3):290\u2013302.","journal-title":"J Int Neuropsychol Soc"},{"key":"1947_CR48","doi-asserted-by":"crossref","unstructured":"Wechsler D. Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). San Antonio: The Psychological Corporation; 1997.","DOI":"10.1037\/t49755-000"},{"key":"1947_CR49","unstructured":"Schmand B, Houx P, De Koning I. Normen voor Stroop kleur-woord tests, trail making test, En story recall Van de Rivermead behavioural memory test. Amsterdam: Nederlands Instituut van Psychologen; 2003."},{"issue":"5","key":"1947_CR50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/JCP.0000000000000941","volume":"38","author":"J Jaeger","year":"2018","unstructured":"Jaeger J. Digit symbol substitution test: the case for sensitivity over specificity in neuropsychological testing. J Clin Psychopharmacol. 2018;38(5):513\u20139.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"1947_CR51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF03079562","volume":"40","author":"H Diesfeldt","year":"2009","unstructured":"Diesfeldt H, Van Der Elst W, Jolles J. Category fluency (animals, professions) in normal cognitive ageing and dementia. Tijdschrift voor Gerontologie en Geriatrie. 2009;40(2):54\u201371.","journal-title":"Tijdschrift voor Gerontologie en Geriatrie"},{"issue":"6","key":"1947_CR52","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jalz.2011.08.006","volume":"8","author":"SA Sikkes","year":"2012","unstructured":"Sikkes SA, de Lange-de Klerk ES, Pijnenburg YA, Gillissen F, Romkes R, Knol DL, et al. A new informant-based questionnaire for instrumental activities of daily living in dementia. Alzheimer\u2019s Dement. 2012;8(6):536\u201343.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"4","key":"1947_CR53","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1037\/0022-006X.44.4.580","volume":"44","author":"BS Wallston","year":"1976","unstructured":"Wallston BS, Wallston KA, Kaplan GD, Maides SA. Development and validation of the health locus of control (HLC) scale. J Consult Clin Psychol. 1976;44(4):580.","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"1947_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/109442810141004","volume":"4","author":"G Chen","year":"2001","unstructured":"Chen G, Gully SM, Eden D. Validation of a new general self-efficacy scale. Organ Res Methods. 2001;4(1):62\u201383.","journal-title":"Organ Res Methods"},{"key":"1947_CR55","doi-asserted-by":"publisher","DOI":"10.2307\/2136319","author":"LI Pearlin","year":"1978","unstructured":"Pearlin LI, Schooler C. The structure of coping. J Health Soc Behav. 1978. https:\/\/doi.org\/10.2307\/2136319.","journal-title":"J Health Soc Behav"},{"key":"1947_CR56","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12913-016-1672-3","volume":"16","author":"L Kerpershoek","year":"2016","unstructured":"Kerpershoek L, de Vugt M, Wolfs C, et al. Access to timely formal dementia care in europe: protocol of the actifcare (ACcess to timely formal Care) study. BMC Health Serv Res. 2016;16:423. https:\/\/doi.org\/10.1186\/s12913-016-1672-3.","journal-title":"BMC Health Serv Res"},{"key":"1947_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1258","author":"GF Moore","year":"2015","unstructured":"Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: medical research council guidance. BMJ. 2015. https:\/\/doi.org\/10.1136\/bmj.h1258.","journal-title":"BMJ"},{"key":"1947_CR58","first-page":"3","volume":"1","author":"T Moyers","year":"2014","unstructured":"Moyers T, Manuel J, Ernst D. Motivational interviewing treatment integrity coding manual 4.1. Unpublished Man. 2014;1:3.","journal-title":"Unpublished Man"},{"issue":"7","key":"1947_CR59","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","volume":"22","author":"M Janssen","year":"2013","unstructured":"Janssen M, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717\u201327.","journal-title":"Qual Life Res"},{"issue":"8","key":"1947_CR60","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.socscimed.2005.08.023","volume":"62","author":"I Grewal","year":"2006","unstructured":"Grewal I, Lewis J, Flynn T, Brown J, Bond J, Coast J. Developing attributes for a generic quality of life measure for older people: preferences or capabilities? Soc Sci Med. 2006;62(8):1891\u2013901.","journal-title":"Soc Sci Med"},{"key":"1947_CR61","unstructured":"Bouwmans C, Hakkaart-van Roijen L, Koopmanschap M, Krol M, Severens H, Brouwer W. iMTA medical consumption questionnaire. Rotterdam: Institute for Medical Technology Assessment, Erasmus Universiteit Rotterdam; 2013."},{"issue":"6","key":"1947_CR62","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jval.2015.05.009","volume":"18","author":"C Bouwmans","year":"2015","unstructured":"Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer W, Hakkaart-van Roijen L. The iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity losses. Value Health. 2015;18(6):753\u20138.","journal-title":"Value Health"},{"key":"1947_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2020.100684","volume":"20","author":"JW Twisk","year":"2020","unstructured":"Twisk JW, Rijnhart JJ, Hoekstra T, Schuster NA, Ter Wee MM, Heymans MW. Intention-to-treat analysis when only a baseline value is available. Contemp Clin Trials Commun. 2020;20:100684.","journal-title":"Contemp Clin Trials Commun"},{"key":"1947_CR64","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e8668","author":"ML Bell","year":"2013","unstructured":"Bell ML, Kenward MG, Fairclough DL, Horton NJ. Differential dropout and bias in randomised controlled trials: when it matters and when it may not. BMJ. 2013. https:\/\/doi.org\/10.1136\/bmj.e8668.","journal-title":"BMJ"},{"issue":"3","key":"1947_CR65","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/alz.12698","volume":"19","author":"A Wimo","year":"2023","unstructured":"Wimo A, Handels R, Antikainen R, Eriksdotter M, J\u00f6nsson L, Knapp M, et al. Dementia prevention: the potential long\u2010term cost\u2010effectiveness of the FINGER prevention program. Alzheimers Dement. 2023;19(3):999\u20131008.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1947_CR66","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jval.2024.07.009","volume":"28","author":"R Handels","year":"2025","unstructured":"Handels R, Herring WL, Grimm S, Sk\u00f6ldunger A, Winblad B, Wimo A, et al. New IPECAD open-source model framework for the health technology assessment of early Alzheimer\u2019s disease treatment: development and use cases. Value Health. 2025;28(4):511\u20138.","journal-title":"Value Health"},{"issue":"5","key":"1947_CR67","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/alz.12811","volume":"19","author":"RL Handels","year":"2023","unstructured":"Handels RL, Green C, Gustavsson A, Herring WL, Winblad B, Wimo A, et al. <article-title update=\"added\">Cost\u2010effectiveness models for Alzheimer\u2019s disease and related dementias: IPECAD modeling workshop cross\u2010comparison challenge. Alzheimers Dement. 2023;19(5):1800\u201320.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1947_CR68","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3233\/JAD-230217","volume":"95","author":"J Bruinsma","year":"2023","unstructured":"Bruinsma J, Heger I, Loukas VS, Kassiotis T, Karanasiou G, Fotiadis DI, et al. Public perspectives on lifestyle-related behavior change for dementia risk reduction: an exploratory qualitative study in The Netherlands. J Alzheimers Dis. 2023;95(4):1635\u201342.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1947_CR69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.14283\/jpad.2023.119","volume":"11","author":"L Bransby","year":"2024","unstructured":"Bransby L, Rosenich E, Maruff P, Lim YY. How modifiable are modifiable dementia risk factors? A framework for considering the modifiability of dementia risk factors. J Prev Alzheimers Dis. 2024;11(1):22\u201337.","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"1947_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06960-z","volume":"24","author":"ML van Dijk","year":"2023","unstructured":"van Dijk ML, Te Loo LM, Vrijsen J, van den Akker-Scheek I, Westerveld S, Annema M, et al. LOFIT (Lifestyle front Office For Integrating lifestyle medicine in the Treatment of patients): a novel care model towards community-based options for lifestyle change\u2014study protocol. Trials. 2023;24(1):114.","journal-title":"Trials"},{"issue":"2","key":"1947_CR71","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/cob.12180","volume":"7","author":"E Burgess","year":"2017","unstructured":"Burgess E, Hassm\u00e9n P, Welvaert M, Pumpa KL. Behavioural treatment strategies improve adherence to lifestyle intervention programmes in adults with obesity: a systematic review and meta-analysis. Clin Obes. 2017;7(2):105\u201314.","journal-title":"Clin Obes"},{"issue":"2","key":"1947_CR72","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s11357-023-00994-0","volume":"46","author":"Y-N Ou","year":"2024","unstructured":"Ou Y-N, Zhang Y-B, Li Y-Z, Huang S-Y, Zhang W, Deng Y-T, et al. Socioeconomic status, lifestyle and risk of incident dementia: a prospective cohort study of 276730 participants. Geroscience. 2024;46(2):2265\u201379.","journal-title":"Geroscience"},{"key":"1947_CR73","unstructured":"Integraal Zorgakkoord. Samen werken aan gezonde zorg. Ministerie van Volksgezondheid; 2022. https:\/\/www.rijksoverheid.nl\/documenten\/rapporten\/2022\/09\/16\/integraal-zorgakkoord-samen-werken-aan-gezonde-zorg."},{"key":"1947_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100576","author":"GB Frisoni","year":"2023","unstructured":"Frisoni GB, Altomare D, Ribaldi F, Villain N, Brayne C, Mukadam N, et al. Dementia prevention in memory clinics: recommendations from the European task force for brain health services. Lancet Reg Health Eur. 2023. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100576.","journal-title":"Lancet Reg Health Eur"},{"key":"1947_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100098","author":"GB Frisoni","year":"2025","unstructured":"Frisoni GB, Ribaldi F, Allali G, Bieth T, Guevara AB, Cappa S, et al. Brain health services for the secondary prevention of cognitive impairment and dementia: opportunities, challenges, and the business case for existing and future facilities. J Prev Alzheimers Dis. 2025. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100098.","journal-title":"J Prev Alzheimers Dis"},{"key":"1947_CR76","doi-asserted-by":"crossref","unstructured":"Albright K, Gechter K, Kempe A. Importance of Mixed Methods in Pragmatic Trials and Dissemination and Implementation Research. Academic Pediatrics. 2013;13(5):400-7.","DOI":"10.1016\/j.acap.2013.06.010"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01947-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01947-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01947-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:03:22Z","timestamp":1770393802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-025-01947-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1947"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01947-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LIGHT has been approved by the medical ethical committee of MUMC+ (NL86513.068.24) and is registered at Dutch trial register OMON (NL-OMON57198) and ClinicalTrials.gov (NCT06832761, registration date February 18th 2025) and is conducted in line with the Declaration of Helsinki. All participants in the study provide written informed consent at the baseline study visit.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RH received outside this study consulting fees in the past 36 months from Lilly Nederland and from the Institute for Medical Technology Assessment (paid to institution). MV received outside this study funding in the past 36 months from ZonMW, Gieskes-Strijbisfonds, Alzheimer Onderzoeksfonds Limburg, Health~Holland, Topsector Life Sciences & Health and Stichting Alzheimer Nederland (paid to institution). SS received outside this study funding in the past 36 months from ZonMW, Health~Holland, Topsector Life Sciens & Health, Innovative Health Initiative Joint Undertaking (IHI JU), NWO and JPND (paid to the institution). SS provided consultancy services for Nationale Nederlanden Ventures, Prothena Biosciences, Aribio Co LTD, Cogstate LTD (paid to institution). Research programs of WF have been funded by ZonMW, NWO, EU-JPND, EU-IHI, Alzheimer Nederland, Hersenstichting CardioVascular Onderzoek Nederland, Health~Holland, Topsector Life Sciences & Health, stichting Dioraphte,\u00a0Noaber foundation, Pieter Houbolt Fonds,\u00a0Gieskes-Strijbis fonds, stichting Equilibrio, Edwin Bouw fonds, Pasman stichting, Philips, Biogen MA Inc, Novartis-NL, Life-MI, AVID, Roche BV, Eli-Lilly-NL, Fujifilm, Eisai, Combinostics. As of 1-11-2025, WF is executive director at Alzheimer Nederland, Amersfoort the Netherlands. Before 1-11-2025, research programs of Wiesje van der Flier have been funded by ZonMW, NWO, EU-JPND, EU-IHI, Alzheimer Nederland, Hersenstichting CardioVascular Onderzoek Nederland, Health~Holland, Topsector Life Sciences & Health, stichting Dioraphte, Noaber foundation, Pieter Houbolt Fonds, Gieskes-Strijbis fonds, stichting Equilibrio, Edwin Bouw fonds, Pasman stichting, Philips, Biogen MA Inc, Novartis-NL, Life-MI, AVID, Roche BV, Eli-Lilly-NL, Fujifilm, Eisai, Combinostics. WF is recipient of ABOARD, which is a public-private partnership receiving funding from ZonMW (#73305095007) and Health~Holland, Topsector Life Sciences & Health (PPP-allowance; #LSHM20106). Before 1-11-2025, WF has been an invited speaker at Biogen MA Inc, Danone, Eisai, WebMD Neurology (Medscape), NovoNordisk, Springer Healthcare, European Brain Council. WF has been consultant to Oxford Health Policy Forum CIC, Roche, Biogen MA Inc, Eisai, Eli-Lilly, Owkin France, Nationale Nederlanden Ventures. WF has participated in advisory boards of Biogen MA Inc, Roche, and Eli Lilly. All funding is paid to her institution. 2024-2025, WF has been member of the steering committee of phase 3 EVOKE\/EVOKE+ studies (NovoNordisk). In 2025, WF has been member of the steering committee op phase 3 Trontinemab study (Roche). All funding has been paid to Amsterdam UMC. WF was associate editor of Alzheimer, Research & Therapy in 2020\/2021. WF was associate editor at Brain 2021-2025. WF is chair of the Scientific Leadership Group of InRAD. WF is member of Supervisory Board (Raad van Toezicht) Trimbos Instituut. MZ received outside this study funding from ZonMw\u2010Memorabel (project no 73305095003), Alzheimer Nederland, Hersenstichting (Dutch Brain Foundation) and Amsterdam Neuroscience; and is trial site coordinator of sponsor-initiated\u00a0studies with AviadoBio and TheriniBio (all paid to institution). All other authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}